Skip to main content
. Author manuscript; available in PMC: 2017 Oct 28.
Published in final edited form as: Circ Res. 2016 Aug 31;119(10):1135–1144. doi: 10.1161/CIRCRESAHA.116.309004

Table 2.

Clinical Characteristics of Validation Cohort (N=35)

Clinical Characteristics N (%) or Median (IQR)
Age, years 45 (39, 57)
Race
 Caucasian 21 (60)
 Black 10 (29)
 Other or unknown 4 (11)
Breast cancer side
 Left 16 (46)
 Right 14 (40)
 Bilateral 5 (14)
Breast cancer nodal status
 N0 15 (43)
 N1 13 (37)
 N2 5 (14)
 N3 2 (6)
Breast cancer hormonal status
 ER+ 18 (51)
Left-sided Radiotherapy 16 (46)
Baseline EF, % 55 (54, 59)
Cancer Therapeutics Related Cardiac Dysfunction, % 18 (51)